Dr. Chang is the Chief Intelligence and Innovation Officer (CIIO) and Medical Director of the Heart Failure Program at Children’s Hospital of Orange County. He has also been named a Physician of Excellence by the Orange County Medical Association and Top Cardiologist, Top Innovators in Healthcare.
He holds an MD from Georgetown, an MPH from UCLA, an MBA from the University of Miami, holds a certification from MIT on AI, and has an MS in Biomedical Data Science from Stanford. He is a computer scientist-in-residence and a member of the Dean’s Scientific Council at Chapman University.
He has helped build a successful startup cardiology practice as a startup company and was able to complete a deal on Wall Street. He is known for several innovations in pediatric cardiac care, including introducing the cardiac drug milrinone and co-designing (with Dr. Michael DeBakey) an axial-type ventricular assist device in children.
Dr. Chang intends to build a clinician-computer scientist interface to enhance all aspects of data science and artificial intelligence in health and medicine. He currently lectures widely on big data and artificial intelligence in medicine (he has been called “Dr. A.I.” by the Chicago Tribune and has given a TEDx talk as well as on the Singularity University faculty). He has published review papers on big data and predictive analytics as well as machine learning and artificial intelligence in medicine. He is on the editorial board of the Journal of Medical Artificial Intelligence. He is currently completing a book project of Intelligence-Based Medicine.
He is the founder and medical director of the Medical Intelligence and Innovation Institute (MI3) that is supported by the Sharon Disney Lund Foundation. And he is the founder of three startup companies in artificial intelligence in medicine:
CardioGenomic Intelligence (CGI), LLC is a multifaceted company that focuses on artificial intelligence applications such as deep learning in clinical cardiology (cardiomyopathy and heart failure as well as other cardiovascular disease) and genomic medicine.
Artificial Intelligence in Medicine (AIMed), LLC is an events company that organizes meetings and educational programs in artificial intelligence in medicine in local as well as global venues.
Medical Intelligence 10 (MI10), LLC is an education and consulting/advising conglomerate for executives and physician leaders as well as investors for the evaluation and implementation of AI strategies in healthcare organizations, for evaluation and recommendation of AI in healthcare vendors, and assessment and implementation of cybersecurity in healthcare orga